Have a personal or library account? Click to login

Prevalence of COPD in Patients with Lung Cancer

Open Access
|Feb 2023

References

  1. 1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of COPD. 2022 [Accessed 2022 Sep 6]. Available from: http://www.goldcopd.org/
  2. 2. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2018. CA: Cancer Clin. 2018; 68:7-30.
  3. 3. Alberg AL, Brock MV, Samet JM. Epidemiology of lung cancer: looking to the future. J Clin Oncol 2005;23:3175-85.
  4. 4. Loganathan RS, Stover DE, Shi W, et al. Prevalence of COPD in women compared to men around the time of diagnosis of primary lung cancer. Chest. 2006;129:1305-12.
  5. 5. American Joint Committee on Cancer (AJCC) Cancer Staging Manual, 8th ed, Amin MB, Edge SB, Greene FL, et al. (Eds), Springer, Chicago 2017.
  6. 6. Congleton J, Muers MF. The incidence of airflow obstruction in bronchial carcinoma, its relation to breathlessness, and response to bronchodilator therapy. Respir Med. 1995;89:291-6.
  7. 7. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD study): a population-based prevalence study. Lancet. 2007;370:741-50.
  8. 8. Young RP, Hopkins RJ, Christmas T et al. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J. 2009;34(2):380-6.
  9. 9. Skillrud DM, Offord KP, Miller RD, et al. Higher risk of lung cancer in chronic obstructive pulmonary disease: a prospective matched controlled study. Ann Intern Med. 1986;105:503-7.
  10. 10. Schwartz AG, Ruckdeschel JC. Familial lung cancer: genetic susceptibility and relationship to chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006;173:16-22.
  11. 11. Brody JS, Spira A. Chronic obstructive pulmonary disease, inflammation, and lung cancer. Proc Am Thorac Soc. 2006;3:535-8.
  12. 12. Park HY, Kang D, Shin SH, et al. Chronic obstructive pulmonary disease and lung cancer incidence in never smokers: a cohort study. Thorax 2020;75(6):506-9.
  13. 13. Howington JA, Blum MG, Chang AC, et al. Treatment of stage I and II non small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e278S-e313S.
  14. 14. Wasswa-Kintu S, Gan W4, Man SF, et al. Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis. Thorax. 2005;60(7):570-5.
  15. 15. Roy E, Rheault J, Pigeon MA, et al. Lung cancer resection and postoperative outcomes in COPD: A single-center experience. Chron Respir Dis. 2020;17:1479973120925430.
  16. 16. Kiri VA, Sorianob JB, Visickc G, Fabbri LM. Recent trends in lung cancer and its association with COPD: an analysis using the UK GP Research Database. Prim Care Resp J. 2010;19(1):57-61.
DOI: https://doi.org/10.2478/amb-2022-0036 | Journal eISSN: 2719-5384 | Journal ISSN: 0324-1750
Language: English
Page range: 18 - 20
Submitted on: Sep 30, 2022
Accepted on: Oct 25, 2022
Published on: Feb 10, 2023
Published by: Sofia Medical University
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year

© 2023 E. Mekov, N. Yanev, N. Kurtelova, T. Mihalova, G. Yankov, Y. Yamakova, R. Petkov, published by Sofia Medical University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.